CD44 and central nervous system cancer: Similar results were obtained for primary glioma cells from mouse (DKO11804 (25); or human (NMA59) tumors (Figures 1C, D), demonstrating that absence of CD44 from cells of the glioma microenvironment disrupts invasion.